Clinical Takeaway Research suggests that standard cannabis prevention messages often fail because they do not account for the range of beliefs adolescents already hold about cannabis use. A multi-step approach that first...
Cannabinoid Clinical Trials: Cannabis in At-Risk Teens
Clinical Takeaway Research suggests that standard anti-cannabis messages often fail because they don't account for the wide range of attitudes adolescents already hold about cannabis. This study tested a sequential messaging approach...
`Cannabinoid Clinical Trials: Cannabis Interventions for Teens`
Clinical Takeaway Scare-tactic cannabis prevention campaigns often fail because teens hold widely different beliefs about the drug, and a one-size-fits-all message rarely lands. This research tested a smarter approach: when a teen...
Cannabinoid Clinical Trials: Cannabis Intervention in Teens
Clinical Takeaway Tailored cannabis prevention messaging that first addresses and refutes adolescents’ negative reactions to anti-cannabis appeals, then delivers a third targeted communication, shows promise as a more effective approach than one-size-fits-all...
Endocannabinoid System Research: Cannabis & HIV Smoking
Clinical Takeaway Digital therapeutics tailored to people living with HIV show promising feasibility and acceptability as a scalable approach to smoking cessation in this high-risk population. Tobacco use remains a leading driver...
Cannabinoid Clinical Trials: Teen Cannabis Intervention Study
Clinical Takeaway Research suggests that standard cannabis prevention messaging often fails teens because it does not account for the wide range of beliefs young people hold about cannabis use. This study tested...
`Cannabinoid Clinical Trials: Digital Smoking Cessation HIV`
Clinical Takeaway A digital therapeutic tailored specifically for people living with HIV showed strong feasibility and acceptability as a smoking cessation tool in this pilot trial, suggesting this population can be reached...